Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2012
10/30/2012US8299320 Modulating plant carbon levels
10/30/2012US8299319 Plants having improved growth characteristics and a method for making the same
10/30/2012US8299318 Nucleotide sequences and corresponding polypeptides conferring modulated plant characteristics
10/30/2012US8299237 Nucleic acid sequences comprising NF-κB binding site within O(6)-methylguanine-DNA-methyltransferase (MGMT) promoter region and uses thereof for the treatment of cancer and immune-related disorders
10/30/2012US8299236 Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells
10/30/2012US8299235 RNA molecules and vectors for gene silencing
10/30/2012US8299234 siRNA hat inhibits WT1 gene expression and uses thereof
10/30/2012US8299231 Nucleic acid sequences encoding AN1-like zinc finger proteins
10/30/2012US8299229 Mucin antigen vaccine
10/30/2012US8299228 Expression of Class 2 mannosidase and Class III mannosidase in lower eukaryotic cells
10/30/2012US8299227 Method of immobilizing and stretching a nucleic acid on a substrate
10/30/2012US8299213 Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses
10/30/2012US8299045 Adenoviral VA1 Pol III expression system for RNAi expression
10/30/2012US8299044 Apoptosis inducer for cancer cell
10/30/2012US8299042 Methods and compositions for silencing genes without inducing toxicity
10/30/2012US8299039 Modulation of growth hormone receptor expression and insulin-like growth factor expression
10/30/2012US8299031 Human semen enhancer of viral infection peptides (SEVI) and their use
10/30/2012US8299027 Method of modulating cell survival and reagents useful for same
10/30/2012US8299018 Proteins with an attached short peptide of acidic amino acids
10/30/2012US8298836 For forming an immune complex with an antigen in an analytical sample and being modified by adding an amino acid sequence comprising a charged amino acid residue and by being labeled with a fluorescent dye
10/30/2012US8298832 Method of agitating solution
10/30/2012US8298826 Chimaeric vector system
10/30/2012US8298821 p185neu-encoding DNA and therapeutical uses thereof
10/30/2012US8298820 Influenza nucleic acid molecules and vaccines made therefrom
10/30/2012US8298819 Cosmid vector for plant transformation and use thereof
10/30/2012US8298818 Self-complementary adeno-associated virus having a truncated CMV-chicken β-actin promoter
10/30/2012US8298817 Vector
10/30/2012US8298816 Expression systems using mammalian beta-actin promoter
10/30/2012US8298811 Expression of Class 2 mannosidase and Class III mannosidase in lower eukaryotic cells
10/30/2012US8298806 Helicobacter system and uses thereof
10/30/2012US8298805 Signal for packaging of influenza virus vectors
10/30/2012US8298803 Polypeptides having arabinofuranosidase activity and polynucleotides encoding same
10/30/2012US8298802 BGL3 beta-glucosidase and nucleic acids encoding the same
10/30/2012US8298800 Lipolytic enzyme variants
10/30/2012US8298799 Hydrolases, nucleic acids encoding them and methods for making and using them
10/30/2012US8298797 Δ-9 elongases and their use in making polyunsaturated fatty acids
10/30/2012US8298790 Methods for effectively coexpressing IL-12 and IL-23
10/30/2012US8298789 Orthogonal process for purification of recombinant human parathyroid hormone (rhPTH) (1-34)
10/30/2012US8298788 Using transgenic escherichia as bioreactor for producing immunoglobulins specific to streptococcal capsular protein for use in treatment and prevention of bacterial infection
10/30/2012US8298785 Use of ribozymes in the detection of adventitious agents
10/30/2012US8298777 Method of identifying transmembrane protein-interacting compounds
10/30/2012US8298771 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
10/30/2012US8298769 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
10/30/2012US8298759 Protein expression yield enhancement in cell-free protein synthesis systems by addition of antifoam agents
10/30/2012US8298758 Method of multiplex microorganism detection
10/30/2012US8298551 Streptococcus pyogenes antigens and corresponding DNA fragments
10/30/2012US8298549 Sequential administration of a replication defective adenovirus vector in vaccination protocols
10/30/2012CA2678572C Mitochondrial targeting and import of a virus to deliver a nucleic acid
10/30/2012CA2669355C Guggulphospholipid methods and compositions
10/30/2012CA2595038C Modified tie-2 receptor ligands
10/30/2012CA2563660C Electromagnetic treatment apparatus and method
10/30/2012CA2525184C Il-23p40 specific immunoglobulin derived proteins, compositions, methods and uses
10/30/2012CA2445938C Hepatitis c inhibitor tri-peptides
10/30/2012CA2411374C Dual specificity antibodies and methods of making and using
10/30/2012CA2395617C Trichoderma reesei xylanase
10/30/2012CA2313240C A starchless variety of pisum sativum having elevated levels of sucrose
10/30/2012CA2257198C Suppression of specific classes of soybean seed protein genes
10/30/2012CA2230111C Antisecretory factor peptides regulating pathological permeability changes
10/30/2012CA2215161C Proteinase k resistant surface protein of neisseria meningitidis
10/29/2012CA2741110A1 Compositions and methods for determining genetic polymorphisms in the tmem216 gene
10/26/2012WO2012145725A2 Oscillating amplification reaction for nucleic acids
10/26/2012WO2012145692A2 Diffusion-based method for obtaining volatile hydrocarbons produced by photosynthetic microorganisms in two-phase bioreactors
10/26/2012WO2012145624A2 Raav-based compositions and methods for treating alpha-1 anti-trypsin deficiencies
10/26/2012WO2012145607A2 Specific copy number aberrations as predictors of breast cancer
10/26/2012WO2012145598A1 Filamentous fungi having an altered viscosity phenotype
10/26/2012WO2012145596A1 Filamentous fungi having an altered viscosity phenotype
10/26/2012WO2012145595A1 Filamentous fungi having an altered viscosity phenotype
10/26/2012WO2012145592A1 Filamentous fungi having an altered viscosity phenotype
10/26/2012WO2012145584A1 Filamentous fungi having an altered viscosity phenotype
10/26/2012WO2012145582A2 Methods and compositions for the specific inhibitions of egfr by double-stranded rna
10/26/2012WO2012145572A1 Regimens and compositions for aav-mediated passive immunization of airborne pathogens
10/26/2012WO2012145523A2 Aav mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity
10/26/2012WO2012145514A2 Compositions and methods for genotyping ces1 genetic variants and use thereof
10/26/2012WO2012145384A1 Beta-2 microglobulin-deficient cells
10/26/2012WO2012145374A1 TARGETING miR-378 FAMILY MEMBERS FOR THE TREATMENT OF METABOLIC DISORDERS
10/26/2012WO2012145269A1 Yield and stress tolerance in transgenic plants
10/26/2012WO2012144906A1 New compounds for treating, delaying and/or preventing a human genetic disorder such as myotonic dystrophy type 1 (dm1)
10/26/2012WO2012144902A1 Hybrid seed potato breeding
10/26/2012WO2012144799A2 Protein skeletal module which increases the binding affinity and binding specificity of active polypeptides
10/26/2012WO2012144692A1 Humanized anti-emap ii antibody and use thereof
10/26/2012WO2012144560A1 Self-gelatinizable nucleic acid
10/26/2012WO2012144512A1 Use of myelin basic protein as a novel genetic factor for rheumatoid arthritis
10/26/2012WO2012144485A1 Method for detecting nucleic acid molecule in biosample
10/26/2012WO2012144472A1 Process for producing l-cysteine
10/26/2012WO2012144446A1 Drug delivery particles and method for producing same
10/26/2012WO2012144220A1 Ezh2 as target gene for cancer therapy and diagnosis
10/26/2012WO2012144208A1 Diagnosis and treatment of cancer using anti-itm2a antibody
10/26/2012WO2012144133A1 Method for electrophoresing nucleic acids, method for concentrating and purifying nucleic acids, cartridge for nucleic acid electrophoresis, and method for producing cartridge for nucleic acid electrophoresis
10/26/2012WO2012143877A2 An expression construct and process for enhancing the carbon, nitrogen, biomass and yield of plants
10/26/2012WO2012143865A1 Plants having enhanced yield-related traits and method for making the same
10/26/2012WO2012143830A1 Plants having one or more enhanced yield-related traits and method for making the same
10/26/2012WO2012143805A1 Methods of modifying lignin biosynthesis and improving digestibility
10/26/2012WO2012143661A1 Method for quantifying living bacteria in a liquid medium
10/26/2012WO2012143545A1 Methods and means to produce abiotic stress tolerant plants
10/26/2012WO2012143543A2 Plants resistant to insect pests
10/26/2012WO2012143542A1 Down-regulating gene expression in insect pests
10/26/2012WO2012143520A1 A method for decreasing the viscosity of flour
10/26/2012WO2012143488A1 Protein for use as a medicament
10/26/2012WO2012143427A1 Anti polyomavirus compounds
10/26/2012WO2012143401A1 Tissue-specific regulation of transgene expression
1 ... 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 ... 4023